{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:27:55Z","timestamp":1792772875279,"version":"4.5.0"},"reference-count":33,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Phlebology"],"abstract":"<jats:p>Facial telangiectasias and reticular veins are common aesthetic concerns for which vascular lasers and light-based therapies are widely used, while the role of sclerotherapy remains less clearly defined. This narrative review evaluates the current evidence regarding the technique, efficacy, and safety of facial sclerotherapy. A literature search identified direct facial studies supplemented by relevant evidence from lower-extremity sclerotherapy and case reports of serious complications. Available studies suggest that liquid sclerotherapy can achieve substantial and durable clearance of selected facial vessels, particularly discrete blue reticular veins. However, the evidence is predominantly derived from small, heterogeneous, and often historical observational studies, and no standardized facial protocol has been established regarding sclerosant, concentration, injection volume, or technique. Facial vascular anatomy represents the principal safety consideration, as inadvertent arterial injection may result in skin necrosis or, rarely, ophthalmic arterial occlusion and permanent visual loss. The relative roles of liquid and foam remain insufficiently defined, while vascular lasers remain more appropriate for most fine telangiectasias and anatomically high-risk vessels. Facial sclerotherapy should therefore be considered a selective treatment requiring careful anatomical assessment, meticulous technique, and individualized risk-benefit evaluation.<\/jats:p>","DOI":"10.1177\/02683555261499783","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:32:45Z","timestamp":1792593165000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Sclerotherapy for facial telangiectasia and reticular veins: Evidence, techniques, anatomical and safety considerations"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1957-5539","authenticated-orcid":false,"given":"Dimitrios A.","family":"Chatzelas","sequence":"first","affiliation":[{"name":"Aristotle University of Thessaloniki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki-Elisavet P.","family":"Stratinaki","sequence":"additional","affiliation":[{"name":"Aristotle University of Thessaloniki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Papas","sequence":"additional","affiliation":[{"name":"Aristotle University of Thessaloniki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Dionyssiou","sequence":"additional","affiliation":[{"name":"Aristotle University of Thessaloniki"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15996"},{"issue":"10","key":"e_1_3_7_3_2","first-page":"CD012723","article-title":"Treatment for telangiectasias and reticular veins","volume":"10","author":"Nakano LC","year":"2021","unstructured":"Nakano LC, Cacione DG, Baptista-Silva JC, et al. Treatment for telangiectasias and reticular veins. Cochrane Database Syst Rev 2021; 10(10): CD012723. https:\/\/doi.org\/10.1002\/14651858.CD012723.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200405060-00007"},{"issue":"1","key":"e_1_3_7_5_2","first-page":"46","article-title":"Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest","volume":"28","author":"Bowes LE","year":"2002","unstructured":"Bowes LE, Goldman MP. Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest. Dermatol Surg 2002; 28(1): 46\u201351. https:\/\/doi.org\/10.1046\/j.1524-4725.2002.01154.x","journal-title":"Dermatol Surg"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17014"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00384-5"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000003382"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000000559"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.5469\/neuroint.2019.00213"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2016.11.023"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjab391"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2010.02325.x"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0000000000003674"},{"issue":"2","key":"e_1_3_7_15_2","first-page":"88","article-title":"Mechanism of action of sclerotherapy","volume":"12","author":"Green D","year":"1993","unstructured":"Green D. Mechanism of action of sclerotherapy. Semin Dermatol 1993; 12(2): 88\u201397.","journal-title":"Semin Dermatol"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1258\/phleb.2009.009043"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1993.tb00976.x"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.1999.08263.x"},{"issue":"3","key":"e_1_3_7_19_2","first-page":"367","article-title":"Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins","volume":"30","author":"Kern P","year":"2004","unstructured":"Kern P, Ramelet AA, Wutschert R, et al. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg 2004; 30(3): 367\u2013372. https:\/\/doi.org\/10.1111\/j.1524-4725.2004.30102.x","journal-title":"Dermatol Surg"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1258\/phleb.2009.009068"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2011.05.093"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-023-03128-4"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-008-9382-9"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.20754"},{"issue":"3","key":"e_1_3_7_25_2","first-page":"373","article-title":"Using silicone gel sheet for the treatment of facial telangiectasias with sclerotherapy","volume":"30","author":"Misirlioglu A","year":"2004","unstructured":"Misirlioglu A, Gideroglu K, Akan M, et al. Using silicone gel sheet for the treatment of facial telangiectasias with sclerotherapy. Dermatol Surg 2004; 30(3): 373\u2013377. https:\/\/doi.org\/10.1111\/j.1524-4725.2004.30103.x","journal-title":"Dermatol Surg"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2023.05.029"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18639"},{"issue":"2","key":"e_1_3_7_28_2","first-page":"133","article-title":"Reasons for ulceration after injection treatment of telangiectasia","volume":"27","author":"Bihari I","year":"2001","unstructured":"Bihari I, Magyar E. Reasons for ulceration after injection treatment of telangiectasia. Dermatol Surg 2001; 27(2): 133\u2013136. https:\/\/doi.org\/10.1046\/j.1524-4725.2001.00298.x","journal-title":"Dermatol Surg"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001876"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000000393"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2007.00256.x"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13504"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16334"},{"issue":"1","key":"e_1_3_7_34_2","first-page":"43","article-title":"Removal of blue periocular lower eyelid veins by ambulatory phlebectomy","volume":"28","author":"Weiss RA","year":"2002","unstructured":"Weiss RA, Ramelet AA. Removal of blue periocular lower eyelid veins by ambulatory phlebectomy. Dermatol Surg 2002; 28(1): 43\u201345. https:\/\/doi.org\/10.1046\/j.1524-4725.2002.01189.x","journal-title":"Dermatol Surg"}],"container-title":["Phlebology: The Journal of Venous Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02683555261499783","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02683555261499783","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02683555261499783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:53:08Z","timestamp":1792763588000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02683555261499783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":33,"alternative-id":["10.1177\/02683555261499783"],"URL":"https:\/\/doi.org\/10.1177\/02683555261499783","relation":{},"ISSN":["0268-3555","1758-1125"],"issn-type":[{"value":"0268-3555","type":"print"},{"value":"1758-1125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"article-number":"02683555261499783"}}